<DOC>
	<DOCNO>NCT00569751</DOCNO>
	<brief_summary>The TAXUS ARRIVE 2 study multi-center safety surveillance study design compile safety surveillance clinical outcome data TAXUS™ Express2™ Paclitaxel-Eluting Coronary Stent System routine clinical practice identify low frequency TAXUS related clinical event .</brief_summary>
	<brief_title>TAXUS ARRIVE 2 : A Multi-Center Safety Surveillance Program</brief_title>
	<detailed_description />
	<mesh_term>Cardiovascular Diseases</mesh_term>
	<criteria>Appropriate Patient Criteria : Patient eligible receive Boston Scientific TAXUS Stent Inappropriate Patient Criteria : Known sensitivity paclitaxel . Known allergy stainless steel . Patients antiplatelet / anticoagulant therapy contraindicate . Patients judged lesion prevents complete inflation angioplasty balloon proper placement stent delivery device . Patients unresolved vessel thrombus lesion site . Patients coronary artery reference vessel diameter less 2.5 mm great 3.75 mm . Patients lesion locate leave main coronary artery , ostial lesion , lesion locate bifurcation . Patients diffuse disease poor overflow distal identified lesion . Patients tortuous vessel region obstruction proximal lesion . Patients recent acute myocardial infarction evidence thrombus poor flow .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2008</verification_date>
	<keyword>de novo</keyword>
	<keyword>coronary</keyword>
	<keyword>coronary artery disease</keyword>
	<keyword>coronary disease</keyword>
</DOC>